TY - JOUR
T1 - Digital phenotyping
T2 - An equal opportunity approach to reducing disparities in Alzheimer's disease and related dementia research
AU - Britton, Gabrielle B.
AU - Huang, Li Kai
AU - Villarreal, Alcibiades E.
AU - Levey, Allan
AU - Philippakis, Anthony
AU - Hu, Chaur Jong
AU - Yang, Cheng Chang
AU - Mushi, Declare
AU - Oviedo, Diana C.
AU - Rangel, Giselle
AU - Ho, Jor Sam
AU - Thompson, Louisa
AU - Khemakhem, Mahdi
AU - Ross, Makayla
AU - Carreira, María B.
AU - Kim, Nicole
AU - Joung, Philip
AU - Albastaki, Omar
AU - Kuo, Po Chih
AU - Low, Spencer
AU - Paddick, Stella Maria
AU - Kuan, Yi Chun
AU - Au, Rhoda
N1 - Publisher Copyright:
© 2023 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
PY - 2023
Y1 - 2023
N2 - A rapidly aging world population is fueling a concomitant increase in Alzheimer's disease (AD) and related dementias (ADRD). Scientific inquiry, however, has largely focused on White populations in Australia, the European Union, and North America. As such, there is an incomplete understanding of AD in other populations. In this perspective, we describe research efforts and challenges of cohort studies from three regions of the world: Central America, East Africa, and East Asia. These cohorts are engaging with the Davos Alzheimer's Collaborative (DAC), a global partnership that brings together cohorts from around the world to advance understanding of AD. Each cohort is poised to leverage the widespread use of mobile devices to integrate digital phenotyping into current methodologies and mitigate the lack of representativeness in AD research of racial and ethnic minorities across the globe. In addition to methods that these three cohorts are already using, DAC has developed a digital phenotyping protocol that can collect ADRD-related data remotely via smartphone and/or in clinic via a tablet to generate a common data elements digital dataset that can be harmonized with additional clinical and molecular data being collected at each cohort site and when combined across cohorts and made accessible can provide a global data resource that is more racially/ethnically represented of the world population.
AB - A rapidly aging world population is fueling a concomitant increase in Alzheimer's disease (AD) and related dementias (ADRD). Scientific inquiry, however, has largely focused on White populations in Australia, the European Union, and North America. As such, there is an incomplete understanding of AD in other populations. In this perspective, we describe research efforts and challenges of cohort studies from three regions of the world: Central America, East Africa, and East Asia. These cohorts are engaging with the Davos Alzheimer's Collaborative (DAC), a global partnership that brings together cohorts from around the world to advance understanding of AD. Each cohort is poised to leverage the widespread use of mobile devices to integrate digital phenotyping into current methodologies and mitigate the lack of representativeness in AD research of racial and ethnic minorities across the globe. In addition to methods that these three cohorts are already using, DAC has developed a digital phenotyping protocol that can collect ADRD-related data remotely via smartphone and/or in clinic via a tablet to generate a common data elements digital dataset that can be harmonized with additional clinical and molecular data being collected at each cohort site and when combined across cohorts and made accessible can provide a global data resource that is more racially/ethnically represented of the world population.
KW - biomarkers
KW - digital technologies
KW - health disparity
KW - minority and vulnerable populations
UR - http://www.scopus.com/inward/record.url?scp=85178245352&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85178245352&partnerID=8YFLogxK
U2 - 10.1002/dad2.12495
DO - 10.1002/dad2.12495
M3 - Article
AN - SCOPUS:85178245352
SN - 2352-8729
VL - 15
JO - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
JF - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
IS - 4
M1 - e12495
ER -